Nxera
NXERA CONTEMPLATIVE PROTEIN 2 8 K

About

We have a clear vision and commitment to build a successful next-generation, technology driven biopharma company making a difference for patients worldwide.

Team

Our Mission

To accelerate the development of life-changing medicines, by investing in science and technology.

Nxera teaser poster

Our Vision

To lead the next era of medicine. From Japan, for Japan, and by extension, to the world.

Basel offices

Our Values

1

Patients, carers, families, and physicians come first

2

Innovation and teamwork inspire success

3

Focus on top priorities where we can make a difference

4

Speed and agility of decision-making

5

Operational excellence

Company History

Our history since establishment

Click on a year to discover more

Sosei Co. Ltd. established in Bunkyo-ku, Tokyo, with the goal of being a biopharmaceutical R&D and technology transfer business

OUR STRATEGY

Our commercial approach aims to maximize success and provide multiple options to advance our own and externally sourced candidates to patients in Japan and globally:

1

In-house development and commercialization of select wholly owned programs for Japan/APAC

2

Late-stage clinical development and commercialization for in-licensed assets in Japan/APAC

3

Partnering assets with early clinical POC for global commercialization, retaining Japan/APAC rights

Getty Images 1446811309 Portrait JPN balcony

Patients Treated

Man contemplating

10,300

with PIVLAZ

Delivering Life-Changing Medicines to Patients in Japan

NXERA CONTEMPLATIVE GLOBULE 1 8 K

Programs

Programs
Stats

Progressing High-Value Programs by Design

NXERA ACTIVE RIBBONS 3 8 K

GPCR structures solved

NXERA ACTIVE RIBBONS 3 8 K

375+

...and counting

Leveraging Cutting-Edge Science and Technology